Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
CAMA-1
HR+
Luminal
LBH589
HDAC
HDAC
10755.154
uM
0.07736
0.10646
-0.7830 -0.7740 2.9289 0.8509
0.9836
1.0198
CAMA-1
HR+
Luminal
LBH589
HDAC
HDAC
12070.154
uM
0.02363
0.03825
-0.9008 -0.9318 2.1846 1.0139
0.9977
1.1006
CAMA-1
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12070.154
uM
0.61156
2.67570
-0.9477 -1.0000 0.7443 0.4513
0.8951
1.1006
CAMA-1
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10755.154
uM
3.98270
7.35970
-0.9711 -1.0000 1.7891 0.3690
0.9281
1.0198
CAMA-1
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10473.142
uM
5.70560
9.9930
-0.9793 -0.9990 1.9591 0.3434
0.9972
1.0815
CAMA-1
HR+
Luminal
Mebendazole
12647.174
uM
0.27826
0.32199
-0.1234 -0.1133 1.3989 0.5322
0.9148
0.9362
CAMA-1
HR+
Luminal
Methotrexate
DHFR
Metabolism
5912.084
uM
0.03731
0.02696
0.2552 0.4014 5.0000 0.4338
0.8849
1.0966
CAMA-1
HR+
Luminal
Methotrexate
DHFR
Metabolism
5911.084
uM
0.12725
0.03793
0.3744 0.4359 1.6963 0.4007
0.9682
1.0262
CAMA-1
HR+
Luminal
Methylglyoxal
13157.184
uM
532.38820
1000.00000
-0.9916 -0.5508 1.1782 0.3945
0.8666
0.8492
CAMA-1
HR+
Luminal
MG-132
Proteasome
Proteasome
14236.189
uM
inf
inf
-0.9745 -0.9745 0.0000 0.7528
0.5730
0.8534
CAMA-1
HR+
Luminal
MG-132
Proteasome
Proteasome
14236.189
uM
inf
inf
-0.9745 -0.9745 0.0000 0.7528
0.5730
0.8534
CAMA-1
HR+
Luminal
MG-132
Proteasome
Proteasome
10755.145
uM
0.17218
0.25004
-0.9524 -0.9359 2.8275 0.8894
0.990
0.7688
CAMA-1
HR+
Luminal
MG-132
Proteasome
Proteasome
10755.145
uM
0.17218
0.25004
-0.9524 -0.9359 2.8275 0.8894
0.990
0.7688
CAMA-1
HR+
Luminal
MG-132
Proteasome
Proteasome
12070.145
uM
0.14703
0.19786
-0.9737 -0.9683 3.6284 0.9299
0.9912
1.0737
CAMA-1
HR+
Luminal
MG-132
Proteasome
Proteasome
12070.145
uM
0.14703
0.19786
-0.9737 -0.9683 3.6284 0.9299
0.9912
1.0737
CAMA-1
HR+
Luminal
Pevonedistat
NAE1
NAE1
10755.148
uM
0.01695
0.04893
-0.4561 -0.5124 0.6654 0.8774
0.9432
0.6379
CAMA-1
HR+
Luminal
Pevonedistat
NAE1
NAE1
12070.135
uM
0.04376
0.04473
-0.0895 -0.0173 1.5605 0.6129
0.9556
1.2457
CAMA-1
HR+
Luminal
Pevonedistat
NAE1
NAE1
10473.135
uM
0.11216
0.11292
-0.0175 -0.0172 5.0000 0.5117
0.9922
1.1592
CAMA-1
HR+
Luminal
Nelfinavir
12647.174
uM
4.63860
8.64280
-0.9213 -1.0000 1.7654 0.3605
0.8914
0.9362
CAMA-1
HR+
Luminal
Nilotinib
ABL
nRTK
12070.145
uM
inf
inf
0.8990 0.8990 0.0000 0.1345
0.0301
1.0737
CAMA-1
HR+
Luminal
Nilotinib
ABL
nRTK
10755.145
uM
inf
inf
0.9059 0.9059 0.0000 0.0960
0.1467
0.7688
CAMA-1
HR+
Luminal
NSC 663284
CDC25
CDC
10755.152
uM
1.8650
2.76950
-0.9988 -1.0000 2.7783 0.7200
0.9787
0.5859
CAMA-1
HR+
Luminal
NSC 663284
CDC25
CDC
12070.159
uM
2.01710
2.54470
-0.9763 -0.9749 4.6561 0.6449
0.9948
0.9846
CAMA-1
HR+
Luminal
NSC 663284
CDC25
CDC
10473.14
uM
2.43380
4.24210
-0.9447 -0.9624 1.9316 0.5953
0.9964
1.3126
CAMA-1
HR+
Luminal
NU6102
CDK1/2
CDK
12070.147
uM
12.58410
15.26170
-0.8106 -0.8118 4.9998 0.2890
0.9010
0.9269